| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT05568212 | Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed… | Non-small-cell Lung Cancer Patients | Recruiting |
| NCT07264647 | Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer… | Stage III NSCLC | Recruiting |
| NCT07264673 | A Randomized Phase II Trial of Cemiplimab Plus OSE2101 ( TEDOPI®) as Maintenance Therapy… | NSCLC | Recruiting |
| NCT07392658 | Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With… | Metastatic NSCLC - Non-Small Cell Lung Cancer | Recruiting |
| NCT04884282 | Efficacy of Tedopi Plus Docetaxel or Tedopi Plus Nivolumab as Second-line Therapy in… | Metastatic Non Small Cell Lung Cancer | Active, Not Recruiting |
| NCT03896074 | Atezolizumab Versus Atezolizumab Plus Bevacizumab as First Line in NSCLC Patients (BEAT) | Non-small-cell Lung Cancer Patients | Active, Not Recruiting |
| Not specified | |||
| NCT06823401 | Study Investigating Anti-drug Antibodies in NSCLC Patients Exposed to Checkpoint… | NSCLC | Recruiting |